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Abstract Activation of several different kinases characterizes
the induction of apoptosis. Abelson virus transformed pre-B
lymphocytes undergo apoptosis within 24 h of serum deprivation,
PKA activation or Q-irradiation, and the activity of two kinases
of ca. 40 and 44 kDa is specifically induced during this apoptotic
process. Bcl-2 expression prevents both apoptosis and the
induction of these kinases. Immunologic and substrate similar-
ities indicate that these kinases are related to the p38 family of
MAP kinases. More mature cells of the B lymphocytic lineage,
plasmacytomas, also exhibit induction of these kinases when
apoptosis is induced by withdrawal of serum or IL-6. Treatment
of the pre-B cells with ICE protease inhibitors when apoptotic
stimuli are delivered prevents induction of the kinase activity, and
partially inhibits apoptosis. These findings indicate that the
induction of these 40 and 44 kDa p38 related kinases is a
common feature of apoptosis in mouse B lymphocytic cells and
may represent a step downstream of ICE proteases in the signal
cascade that leads to programmed cell death.
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1. Introduction
Apoptosis is a common and highly regulated mechanism of
programmed cell death. Apoptosis is essential during the de-
velopment of higher organisms, and failure to undergo apop-
tosis appears to be one of the key events that lead to the
development of malignancies [1^3]. In particular, apoptosis
is an important mechanism that regulates the population ho-
meostasis in the hematopoetic cell compartment [4,5]. During
the maturation of B and T lymphocytic cells, autoreactive
cells are eliminated by apoptosis, and apoptosis also serves
to terminate immune responses at the appropriate time [6^
8]. Failure to undergo apoptosis has been linked to the devel-
opment of several hematopoetic malignancies, most notably B
cell neoplasms, such as follicular lymphomas, in which the
anti-apoptotic gene bcl-2 was ¢rst discovered at the site of a
characteristic chromosomal translocation [9,10]. The biochem-
ical function of bcl-2 remains controversial, but it is well
documented that bcl-2 can protect various cell types against
a broad range of apoptotic signals [6,8].
Apoptosis can be induced by a wide variety of stimuli, in-
cluding ionizing radiation, activation of several cell surface
receptors or deprivation of growth factors [1,11,12]. While
the mechanisms of induction of apoptosis can be quite di¡er-
ent, the intracellular components of the apoptotic machinery
are highly conserved, since various apoptotic signals seem to
converge into common intracellular pathways [5,7]. Based on
genetic studies in Caenorhabditis elegans, an ICE (interleukin
1L converting enzyme)-like protease cascade has been discov-
ered that becomes activated during apoptotic cell death [5].
The proteases are synthesized as inactive proenzymes that
become activated by speci¢c proteolysis at aspartate residues.
The activation of the cascade remains enigmatic, although the
recent cloning of a Fas associated protease, termed FLICE/
MACH/Mch-5, suggests that Fas may trigger apoptosis by
direct activation of this protease cascade [13,14]. How these
events e¡ect the subsequent steps that result in activation of
additional genes in the ‘death program’ is unclear.
Recent data also suggest that MAP kinases (MAPK) are
involved in the regulation of apoptosis. The MAPK super-
family comprises the mitogen induced ERK kinases and the
stress activated kinases, JNK/SAPK, and p38. ERK activa-
tion has been shown to counteract apoptosis in some cells
[15,16]. The role of the stress activated kinases is less clear.
These kinases are activated by many stimuli that also induce
apoptosis, e.g. UV irradiation, tumor necrosis factor K and
growth factor withdrawal. Transfection experiments showed
that dominant negative JNK and p38 mutants can block
apoptosis in PC12 cells triggered by NGF deprivation [15].
On the other hand, JNK activation promotes T cell survival
[17]. The situation is further complicated by a methodological
ambiguity stemming from the fact that in many reports JNK
activity was examined using immobilized GST-c-Jun to pre-
cipitate JNK from cell lysates. This type of assay for JNK and
p38 activity may be of insu⁄cient speci¢city, since it is pos-
sible that kinases other than JNK and p38 bind to c-Jun.
Therefore, we decided to explore this possibility using in-gel
assays to detect kinases that become activated during growth
factor deprivation induced apoptosis of B cells. This method
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provides a more general survey of kinase activities, and it
appears to be better suited for the purpose of screening for
kinases involved in the apoptotic process.
Our results show that the kinetics of the onset of apoptosis
in B cells correlates with the activation of two novel kinases
with apparent molecular weights of 40 and 44 kDa. These
kinases appear to be immunologically and biochemically re-
lated to the p38 kinase, since they are detectable with an anti-
p38 antibody and can bind to and phosphorylate c-Jun. The
activation of these kinases can be inhibited by the use of ICE-
like protease inhibitors, suggesting that they are downstream
of this protease cascade.
2. Materials and methods
2.1. Cell culture, virus infection, and reagents
All cells were grown at 37‡C/5% CO2 in RPMI 1640 supplemented
with 10% fetal calf serum and 2 mM glutamine. The medium for
TEPC 1165 was further supplemented with 1 ng/ml IL-6 (Gibco
BRL). For serum starvation, cells were washed twice and subse-
quently cultured in the same medium without serum. Helper-free
Abelson virus was generated as described previously [18]. The bcl-2
expressing plasmid, pLbclSN, was constructed by inserting the mouse
bcl-2 cDNA into the LXSN retroviral expression vector. The bcl-2
expressing retrovirus was generated by transfecting pLbclSN into the
82 packaging line. The cells were selected for G418 resistance with
1 mg/ml G418 (Gibco BRL) for 14 days and kept as bulk culture. To
generate the BA (cells overexpressing v-abl) cell line, freshly isolated
bone marrow cells from BALB/c mice were infected with helper-free
Abelson virus as described [18]. To generate the BAB (cells overex-
pressing abl and bcl-2) cell line, BA cells were infected with LbclSN
virus and subsequently selected for G418 resistance as described
above.
2.2. Immunoprecipitation and kinase assays
Cell lysates (lysis bu¡er: 20 mM Tris-HCl, pH 7.4, 150 mM NaCl,
2 mM EDTA, 1% Triton X-100) supplemented with protease inhib-
itors (1 mM phenylmethylsulfonyl £uoride (PMSF) and 1 Wg/ml leu-
peptin) and phosphatase inhibitors (20 WM L-glycerophosphate, 2 WM
sodium orthovanadate, 2 WM sodium £uoride and 2 WM sodium py-
rophosphate) were immunoprecipitated as described [19] using an
anti-ERK serum [19] or an anti-JNK serum (Santa Cruz) coupled
to protein A agarose. Precipitates were washed three times in TBST
and once with kinase bu¡er A (20 mM Tris-HCl, pH 7.4, 20 mM
NaCl, 10 mM MgCl2, 1 mM DTT). Kinase activity was determined in
kinase bu¡er in the presence of 10 WM ATP/[Q-32P]ATP (speci¢c ac-
tivity 30 Ci/mmol) using 2 Wg myelin basic protein (MBP) or 2 Wg
GST-Jun as substrates in a total volume of 30 Wl. The reactions were
incubated at 30‡C for 20 min, resolved on 12.5% SDS-polyacrylamide
gels and the gels autoradiographed.
2.3. GST-Jun pulldown assays
Cell lysates were incubated for 2 h at 4‡C with 5 Wg GST-Jun fusion
protein bound to glutathione-Sepharose. The precipitates were washed
three times with PBS containing 1% NP-40 and 2 mM orthovanadate
and once with kinase bu¡er B (15 mM Tris-HCl, pH 7.5, 20 mM
NaCl, 7.5 mM MgCl2, 1 mM DTT, 0.5 mM EGTA). GST-Jun phos-
phorylation was measured as speci¢ed above in Section 2.2.
2.4. In-gel kinase assays
15 Wg of cell lysate was resolved on a 10% SDS-PAGE containing
0.2 mg/ml substrate protein (myelin basic protein or GST-Jun). The
gel was washed twice for 20 min with 150 ml of 50 mM HEPES pH
7.4, 5 mM 2-mercaptoethanol, and 20% isopropanol. After equilibra-
tion for 2U10 min at room temperature with 150 ml 50 mM HEPES
pH 7.4 and 5 mM 2-mercaptoethanol, the proteins were denatured by
incubating the gel twice for 30 min at room temperature with 150 ml
of 6 M guanidine-HCl in 50 mM HEPES pH 7.4, 5 mM 2-mercap-
toethanol. The proteins were renatured overnight at 4‡C with three
changes of 150 ml 50 mM HEPES pH 7.4, 5 mM 2-mercaptoethanol
containing 0.04% Tween 20. The gel was equilibrated for 15 min at
room temperature in in-gel kinase bu¡er (25 mM HEPES pH 7.4,
5 mM 2-mercaptoethanol, 10 mM MgCl2, 90 WM sodium orthovana-
date) and subsequently placed in fresh in-gel kinase bu¡er containing
250 WCi [Q-32P]ATP (speci¢c activity 3000 Ci/mmol) for 1 h at 30‡C.
The gel was washed four times for 2^3 h in 500 ml 5% trichloroacetic
acid/10 mM sodium pyrophosphate, dried and exposed to X-ray ¢lm.
2.5. Western blot analysis
Proteins were resolved on 10% SDS-PAGE and electroblotted.
Blots were blocked with 5% non-fat dry milk for 30 min and incu-
bated in primary and, after extensive washing with Tris bu¡ered saline
(TBS) and 1% Tween 20, in secondary antibody (Dianova) for 1 h
each. The primary antibodies used were rabbit antisera against JNK
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Fig. 1. A: Time course of the induction of apoptosis in BA cells and its absence in BAB cells. Cells were serum starved for the time indicated
at the top of each lane and refed with medium containing serum for 18^24 h. Subsequently, DNA was isolated and loaded on a 2% agarose
gel. While essentially no apoptotic laddering can be observed in the DNA isolated from BAB cells, the appearance of apoptotic ladders is easily
visible in the DNA isolated from BA cells that were serum starved for at least 8 h. B: In-gel kinase assay of cell lysates from BA or BAB cells
that were serum starved for the times indicated on the top. The sizes and positions of protein molecular weight markers are indicated on the
left. This experiment was repeated ¢ve times with comparable results.
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from Santa Cruz, against the C-terminus and the N-terminus of p38
from Santa Cruz, against full-length p38 (a kind gift from Brent
Zanke, Smith Kline Beecham Pharmaceuticals), a mouse monoclonal
antibody against v-abl from Oncogene Science and a hamster mono-
clonal antibody against bcl-2 from Biomol. Immunoreactive bands
were visualized using the ECL system (Amersham).
2.6. Apoptosis assays
To monitor endonucleosomal DNA fragmentation, genomic DNA
was isolated as described [18]. 5 Wg of DNA per lane was electro-
phoresed at 80 V for 4 h on a 2% agarose gel in TAE bu¡er (40
mM Tris, 20 mM acetic acid, 1 mM EDTA). The DNA was stained
with ethidium bromide. To quantify the number of apoptotic cells the
APOALERT Annexin V Apoptosis Kit (Clontech) was used. Apop-
totic cells were counted using a £uorescence microscope.
3. Results
To study kinases that become activated during the process
of apoptosis in B cells, we used v-abl transformed mouse pre-
B cells. We had determined earlier that such pre-B cell lines
undergo rapid apoptosis (within 24 h) when serum is with-
drawn [18]. To avoid artifacts due to the use of a cell line that
had been in culture for several years, a bulk culture of freshly
transformed cells (BA) was generated by infecting 106 BALB/c
bone marrow cells with 107 focus forming units (¡u) of help-
er-free Abelson murine leukemia virus as described [18]. As
bcl-2 overexpression leads to apoptosis inhibition, we gener-
ated the BAB cell line as a control: 107 of the BA cells were
infected with LbclSN virus, a mouse bcl-2 expressing retrovi-
rus, and selected for G418 resistance. Expression of both v-abl
and bcl-2 was con¢rmed by Western blot (not shown).
First, we determined the time point when apoptosis be-
comes irreversible (Fig. 1A). For this purpose BA and BAB
cells were serum starved for 2^24 h, and then refed with me-
dium containing serum. 24 h later genomic DNA was ex-
tracted and examined for endonucleosomal cleavage. While
no sign of apoptotic DNA was detectable in the BAB cells,
the ¢rst appearance of apoptotic DNA ladders was detected in
the BA cells after serum starvation for 6^8 h. This suggests
that after this period of serum starvation the apoptotic path-
way has been irreversibly activated.
To examine kinases that become activated during apopto-
sis, cells were harvested at di¡erent time points after serum
deprivation and analyzed by in-gel kinase assays using MBP
substrate gels (Fig. 1B). Serum deprived BA cells, which
showed ¢rst signs of apoptosis after 6^8 h, also revealed a
consistent and strong activation of kinases with apparent mo-
lecular weights of ca. 40 and 44 kDa, beginning at about the
same time. This size falls into the range of MAP kinases,
which have been implicated in the regulation of apoptosis
[15,20^22]. Therefore, we examined the activation of these
kinases during B cell apoptosis.
To facilitate comparison of our data with recent reports on
p38 and JNK activation, we also assayed the kinase activity
isolated by GST-Jun pulldowns from cells harvested at di¡er-
ent times after serum deprivation. In parallel experiments, we
examined the activity of the classical MAP kinases, ERK-1
and -2, as well as of JNK isolated by immunoprecipitation.
We could not directly examine p38 activity by immunocom-
plex kinase assay, since no antibody against p38 suitable for
immunoprecipitation kinase assays was available. In addition,
we monitored the appearance of apoptotic DNA ladders. As
shown in Fig. 2A, while no induction of ERK activity could
be observed during the time course of the experiment, a kinase
activity that can be precipitated with an anti-JNK antiserum
was induced up to four-fold between 8 and 12 h after serum
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Fig. 3. p38 and JNK expression in BA and BAB cells. Duplicate
Western blots were stained with antibodies against (A) the C-termi-
nus of p38, (B) the N-terminus of p38, (C) GST-p38 (full-length
p38), and (D) JNK. COS cells transfected with HA tagged p38 or
HA tagged JNK-1 expression vectors were used as positive controls.
Lanes 1: COS/p38, 2: COS/JNK-1, 3: BA, 4: BAB. The size and
position of protein molecular weight markers is indicated on the
left. This experiment was repeated three times with comparable re-
sults.
Fig. 2. Induction of Erk, JNK, and c-Jun binding kinase activity
upon serum deprivation. Cell lysates of BA (abl) or BAB (abl-bcl-2)
cells that had been serum starved for the time indicated at the top
of the ¢gure were precipitated using the antibodies or a GST-Jun
expression protein as indicated on the right. The precipitates were
washed and tested for kinase activity using either MBP as a sub-
strate, for the immunoprecipitates, or the precipitating GST-Jun
protein itself for the pulldowns. A: Kinase reactions were resolved
on SDS gels and exposed to X-ray ¢lm. B: As a control for the
amount of ERK, JNK, and p38 present in the cell lysates, Western
blots of the crude lysates were probed with antibodies speci¢c for
the respective kinases. Antisera used were an anti-ERK1, -2 anti-
body [19], anti-JNK (Santa Cruz) and anti-full-length p38 (Dr.
Zanke). Note that the anti-p38 antibody detects two bands (see also
Fig. 3C).
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withdrawal. Another kinase activity was pulled down with
GST-Jun several hours earlier. This activity was consistently
induced to a much higher level (10^20-fold), and at the time
points that coincide with the minimal time of serum starvation
required for the irreversible induction of apoptosis in these
cells. Since the changes observed in activity were evident after
a rather long period of time (6 h and more), we wanted to
determine if they might be due to changes in the amount of
protein present. To this end, we performed Western blot anal-
ysis using antibodies against ERK, JNK, and p38. As shown
in Fig. 2B, the amount of these kinases did not change sig-
ni¢cantly during the time course, with exception of a decrease
in ERK in the BAB cells. Western blot analysis of the proteins
associated with GST-Jun in the pulldown assays revealed that
both p38 and JNK were present in the complex (data not
shown).
p38 seems to be activated, at least in part, by signals that
also activate JNK [23]. Furthermore, p38’s apparent molecu-
lar weight of 38 kDa is close to the molecular weight of the
apoptosis associated kinases described here. Therefore, ex-
pression of p38 and JNK in BA and BAB cells was examined
by Western blotting using di¡erent anti-p38 and anti-JNK
antibodies (Fig. 3). HA tagged p38 (lane 1) and JNK-1
(lane 2) expressed in COS-1 cells were used as positive con-
trols. Endogenous p38 can be detected in both COS controls
(lanes 1 and 2), in BA (lane 3), and BAB (lane 4) cells as a ca.
44 kDa protein with antibodies against either the C- (Fig. 3A)
or N-terminus (Fig. 3B) of p38. The bands at ca. 120 and 80
kDa in Fig. 3A are only detected by the antibody against the
C-terminus of p38 and hence do not seem to represent p38
related proteins. In the HA transfected COS cells two p38
speci¢c bands are detectable. The smaller one, migrating at
about 44 kDa, represents the endogenous p38, whereas the
larger band corresponds to HA-p38, whose triplicate HA
tag increases the molecular weight by approximately 4 kDa.
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Fig. 5. Time course of the induction of apoptosis in BA cells and its absence in BAB cells. Cells were either irradiated with 20 Gy of Q-rays
and harvested after the time indicated or stimulated with 100 WM 8-Cl-cAMP for the time indicated. A: In-gel kinase assays of the cell lysates.
The size and position of protein molecular weight markers are indicated on the left. This experiment was repeated two times, and the kinetics
of induction of p40 and p44 were consistent with the results shown here, while BAB cells showed only occasional dark bands at various time
points after irradiation, depending on the experiment. B: Percentage of apoptotic cells after treatment. The cells were washed with PBS and re-
suspended in binding bu¡er. Annexin-V-FITC was added and incubated for 20 min in the dark. Stained cells were then counted in a £uores-
cence microscope. 300 cells were counted for each point.
Fig. 4. In-gel kinase assay using GST-Jun as a substrate of cell ly-
sates from BA or BAB cells that were serum starved for the times
indicated at the top. The sizes and positions of protein molecular
weight markers are indicated on the left.
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A polyclonal antibody raised against full-length p38 recog-
nizes the transfected HA tagged p38 as well as the endogenous
p38 of the COS cells in Fig. 3C. In the BA and BAB cells this
antiserum detects the 44 kDa band and an additional smaller
band of about 40 kDa. This pattern corresponds to the pat-
tern seen in in-gel kinase assays in Fig. 1. The K-JNK anti-
body speci¢cally detected a 48 kDa protein in HA-JNK-1
transfected COS cells (lane 2, Fig. 3D). It totally failed to
react with HA-p38 or endogenous p38 in the COS control
cells, thus con¢rming the speci¢city of this antibody for
JNK. In BA and BAB cells the anti-JNK antibody preferen-
tially detected a 56 kDa protein. As at least 10 di¡erentially
spliced JNK transcripts have been described [24], the 56 kDa
protein most likely represents an isoform of the JNK protein
that is predominantly expressed in the BA and BAB cells.
In sum, this Western blot analysis suggests that the 40 and
44 kDa kinases activated during B cell apoptosis are di¡erent
from JNKs, but may be related to p38 kinases. The p44 band
probably corresponds to the known p38, as it is detected by
all three antisera used. The p40 band does not react with the
antisera made against synthetic peptides derived from the C-
or N-terminus of p38. It is recognized, however, by a poly-
clonal serum raised against a full-length p38 protein.
If the two kinases described here were in fact members of
the p38 family, they should also be able to accept GST-Jun as
a substrate in in-gel assays. To this end, cell lysates of serum
starved BA and BAB cells were examined in an in-gel kinase
assay using GST-Jun as a substrate. In this experiment, as was
observed in Fig. 1B using MBP as a substrate, the activity of
the two kinases was induced several fold in the BA cells, while
no signi¢cant increase could be observed in the BAB cells
(Fig. 4). To prove that the incorporation of 32P in the bands
is due to substrate and not to autophosphorylation, we also
performed an in-gel assay omitting any substrate in the gel.
Under these conditions, where autophosphorylation still oc-
curs, no kinase activity of the p40/44 kinases could be de-
tected (data not shown).
To rule out the possibility that the activation of the p40/44
kinases is a peculiar consequence of serum withdrawal rather
than speci¢cally linked to apoptosis, we investigated whether
these kinases could also be activated by other apoptotic stim-
uli. To this end, BA and BAB cells were either irradiated with
Q-rays (20 Gy) or treated with 8-Cl-cAMP, which induces
apoptosis via PKA mediated inhibition of Raf-1 [25] (Fig.
5A,B). Irradiation readily induced apoptosis in BA cells,
which began at 6 h and peaked between 18 and 24 h (Fig.
5B). At these late time points there was also a modest increase
of apoptosis in BAB cells. 8-Cl-cAMP elicited a modest rate
of apoptosis in both BA and BAB cells between 6 and 10 h
(Fig. 5B). The apoptosis in BAB cells, however, declined be-
tween 16 and 24 h, whereas in BA cells it progressed to very
high levels. The apoptotic response was largely re£ected in the
activation pattern of the p40 and p44 kinases (Fig. 5A). The
greater extent of apoptosis in BA cells correlated with a more
pronounced kinase activation. Moreover, in these cells irradi-
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Fig. 7. E¡ect of inhibition of ICE protease on induction of apopto-
sis and kinase activity by 8-Cl-cAMP (100 WM) and their inhibition
of Z-VAD. A: In-gel kinase assays of lysates of the BA cells with
MBP as a substrate, after the treatments listed above. The concen-
trations of the inhibitors are indicated on the top. B: Percentage of
apoptotic cells after 20 h of treatment. The cells were washed with
PBS, treated with annexin-V-FITC, incubated for 20 min in the
dark and counted in a £uorescence microscope. 300 cells were
counted for each point, and the experiment was repeated twice.
Fig. 6. Time course of the induction of apoptosis in two plasmacy-
toma cell lines. Apoptosis was induced in ABPC 20 cells by serum
starvation, while IL-6 was withdrawn from the IL-6 dependent cell
line TEPC 1165. The extent of apoptosis was determined and the
cell lysates collected at the time points indicated at the top of the
¢gures. In-gel assays were performed with the cell lysates. The sizes
and positions of protein molecular weight markers are indicated on
the left. This experiment was repeated three times, always showing
similar results.
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ation induced early apoptosis and early onset of kinase acti-
vation. 8-Cl-cAMP triggered massive apoptosis as well as kin-
ase activation only at the late time points. Some variation in
the kinase activity could be observed during the time course
(e.g. an apparent lower activity at 12 h than at 8 or 18 h after
irradiation of the BA cells). These small decreases and in-
creases, however, change from experiment to experiment
and hence are not signi¢cant.
To test whether our ¢ndings could be extended to more
mature B cell lines, we utilized plasmacytoma cell lines, where
apoptosis was induced ca. 4^6 h after withdrawal of either
serum, from the cell line ABPC 20, or IL-6, from the IL-6
dependent cell line TEPC1165. Again, robust activation of the
40 and 44 kDa kinases coincided temporally with the induc-
tion of apoptosis (Fig. 6). Hence, the activation of the 40/44
kDa kinases during the induction of apoptosis is seen in early
and late stage B lineage cells.
To investigate where these kinases could be placed in the
apoptosis pathway relative to the ICE-like proteases, BA cells
were treated with the caspase inhibitor Z-VAD. BA cells were
stimulated with the membrane permeable PKA activator 8-Cl-
cAMP and simultaneously incubated with varying concentra-
tions of Z-VAD. After 20 h the cells were harvested, and
apoptotic cells were detected by annexin staining (Fig. 7B).
Z-VAD could substantially protect BA cells from 8-Cl-cAMP
induced apoptosis, and, as shown in Fig. 7A, could inhibit the
activation of the 40/44 kDa kinases in a dose dependent man-
ner. These results place the activation of the 40/44 kDa kin-
ases downstream of the ICE protease cascade.
4. Discussion
Our results reveal two kinases of 40 and 44 kDa that are
activated during the execution phase of apoptosis in pre-B
and plasmacytoma cells lines, early and late stage cells of
the B cell lineage. Lu et al. [26] and Cahill et al. [27] have
recently reported the activation of kinases of similar molec-
ular weights during apoptosis, but it is unclear whether these
kinases correspond to the kinases described here. Other
groups reported that activation of JNK and/or p38 accompa-
nies the induction of apoptosis [15,20^22], and our results
con¢rmed these ¢ndings. However, our data indicate that
JNK was certainly not the main c-Jun phosphorylating kinase
present (Fig. 3). Instead, two kinases of p40/44 molecular
weight predominate in our system. Since the p44 kinase is
recognized by three di¡erent p38 antisera, it most likely rep-
resents p38. The p40 kinase only reacts with an antiserum
raised against the full-length p38 protein, but not with anti-
peptide sera speci¢c for the N- or C-terminus, respectively.
This is not unexpected, inasmuch as the members of the p38
family known at present share hardly any homology in their
extreme C- and N-terminal regions, while the core kinase
domain appears to be highly conserved. Hence, only antisera
directed against the entire protein should be able to detect
additional p38 family members. Thus, the p40 kinase may
represent a novel member of the p38 family. This notion is
additionally supported by the substrate speci¢city of this kin-
ase. Like p38, it accepts both MBP and GST-Jun as a sub-
strate in the in-gel assays. (Figs. 1 and 4). Furthermore, the
activity of both kinases could be induced by treatment of the
cells with anisomycin, a known activator of p38 (data not
shown).
Our kinetic analysis showed that the activation of the p40/
44 kinases occurs at the time point where apoptosis becomes
irreversible (Fig. 1). By use of di¡erent apoptotic stimuli we
further showed that the kinetics of apoptosis induction corre-
lated with the kinetics of kinase activation (Fig. 5). Because
endogenous expression of bcl-2 does not completely inhibit
apoptosis of these cells, a small but signi¢cant amount of
kinase activation can be observed. These results demonstrate
that the activation of the p40/44 kinases is tightly linked to the
apoptotic process. Furthermore, activation of the p40/44 kin-
ases can be inhibited by the caspase inhibitor Z-VAD. These
data suggest that the p40/44 kinases fall downstream of the
caspase protease in the cascade of reactions that lead to apop-
tosis.
These observations point to a causal relationship between
the induction of apoptosis and the activation of the p40/44
kinases. It remains open, however, whether the p40/44 kinases
are involved in the induction of apoptosis or whether their
activation is a consequence of the execution of the apoptotic
program. The resolution of this question has to await further
studies, such as the puri¢cation and direct identi¢cation of the
p40/44 kinases, which is currently under way in our labora-
tory.
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